EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Clinical Profile, Short and Long-Term Outcomes of Non-Ischaemic Cardiogenic Shock: A FRENSHOCK Sub-Analysis

Miloud Cherbi, François Roubille, Edouard Gerbaud, Eric Bonnefoy, Nicolas Lamblin, Laurent Bonello, Bruno Levy, Pascal Lim, Hamid Merdji, Meyer Elbaz, Hadi Khachab, Jeremy Bourenne und 9 weitere

ESC Heart Failure · 01.06.2025 · 12 (3) · 2335-2346

DOI: 10.1002/ehf2.15046 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, online erschienen am 25.03.2025. Verfasst von Miloud Cherbi und 20 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Cardiac Care Unit, Rangueil University Hospital, Toulouse, France. Hauptthemen laut MEDLINE: Shock, Cardiogenic, Registries. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fédération Française de Cardiologie, Daiichi-Sankyo, Maquet SAS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Although predominant in routine practice, non-ischaemic cardiogenic shock (NICS) remains underrepresented in past studies, mainly focused on ischaemic cardiogenic shock (CS). This study aims to describe the current NICS picture and define its independent correlates of short- and long-term outcomes. Methods and results FRENSHOCK is a prospective registry including 772 CS patients from 49 centers. One-year mortality was the primary outcome. One-month mortality and the composite of 1-year mortality, heart transplantation (HTx), or ventricular assistance device (VAD) were secondary outcomes. Within 772 patients included, 492 (63.7%) were NICS. One-month and 1-year mortality rates were 25.6% and 45.7%, with a combined endpoint of 1-year mortality, HTx, or VAD of 53.9%. Multivariate analysis showed five independent factors for 1-year mortality: age (per year: aHR 1.03 [1.01–1.05], P < 0.01), chronic kidney disease (CKD) (aHR 1.87 [1.25–2.80], P < 0.01), norepinephrine use (aHR 1.52 [1.02–2.26], P = 0.04), active cancer (aHR 1.91 [1.07–3.42], P = 0.03) and acute renal replacement therapy (aHR 1.57 [1.01–2.46], P = 0.049). Age, CKD and norepinephrine were also predictive of 1-month mortality and 1-year mortality and/or HTx and/or VAD. Additionally, 1-month mortality was associated with septic triggers, and 1-year mortality and/or HTx and/or VAD with acute mechanical circulatory support, NYHA stage ≥ 3 and fluid administration.

Conclusions

In this large study, NICS accounted for almost two-thirds of all CS cases, with substantial rates of short- and long-term mortality. Future studies should evaluate interventions to improve early stratification and management. NCT02703038.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shock, CardiogenicRegistriesHumansFemaleMaleMiddle AgedProspective StudiesTime FactorsSurvival RateFollow-Up StudiesHeart-Assist DevicesAgedRisk FactorsHeart Transplantation

Stichwörter der Autor:innen

Cardiogenic shockEpidemiologyMortalityPrognosis

Autor:innen und Institutionen

  • Intensive Cardiac Care Unit, Rangueil University Hospital, Toulouse, France.
  • PhyMedExp, Université de Montpellier, INSERM, CNRS, Cardiology Department, CHU de Montpellier, Montpellier, France.
  • Intensive Cardiac Care Unit and Interventional Cardiology, Hôpital Cardiologique du Haut Lévêque, Pessac, France.
  • Bordeaux Cardio-Thoracic Research Centre, U1045, Bordeaux University, Hôpital Xavier Arnozan, Pessac, France.
  • Intensive Cardiac Care Unit, Lyon Brom University Hospital, Lyon, France.
  • Urgences et Soins Intensifs de Cardiologie, CHU Lille, University of Lille, Lille, France.

Förderung

  • Fédération Française de Cardiologie
  • Daiichi-Sankyo
  • Maquet SAS

Zitieren

APA

Cherbi, M., Roubille, F., Gerbaud, E., Bonnefoy, E., Lamblin, N., Bonello, L., Levy, B., Lim, P., Merdji, H., Elbaz, M., Khachab, H., Bourenne, J., Seronde, M. F., Schurtz, G., Harbaoui, B., Vanzetto, G., Combaret, N., Lattuca, B., Leurent, G., …, & Delmas, C. (2025). Clinical Profile, Short and Long-Term Outcomes of Non-Ischaemic Cardiogenic Shock: A FRENSHOCK Sub-Analysis. ESC Heart Failure, 12(3), 2335-2346. https://doi.org/10.1002/ehf2.15046

Vancouver

Cherbi M, Roubille F, Gerbaud E, Bonnefoy E, Lamblin N, Bonello L, et al. Clinical Profile, Short and Long-Term Outcomes of Non-Ischaemic Cardiogenic Shock: A FRENSHOCK Sub-Analysis. ESC Heart Failure. 2025;12(3):2335-2346. doi:10.1002/ehf2.15046

BibTeX
@article{Cherbi2025,
  author = {Cherbi, Miloud and Roubille, François and Gerbaud, Edouard and Bonnefoy, Eric and Lamblin, Nicolas and Bonello, Laurent and Levy, Bruno and Lim, Pascal and Merdji, Hamid and Elbaz, Meyer and Khachab, Hadi and Bourenne, Jeremy and Seronde, Marie-France and Schurtz, Guillaume and Harbaoui, Brahim and Vanzetto, Gerald and Combaret, Nicolas and Lattuca, Benoit and Leurent, Guillaume and Puymirat, Etienne and Delmas, Clément},
  title = {Clinical Profile, Short and Long-Term Outcomes of Non-Ischaemic Cardiogenic Shock: A FRENSHOCK Sub-Analysis},
  journal = {ESC Heart Failure},
  year = {2025},
  volume = {12},
  number = {3},
  pages = {2335--2346},
  doi = {10.1002/ehf2.15046}
}
Kostenlos starten →